论文部分内容阅读
目的:评估和观察金双歧联合思密达治疗小儿腹泻疗效。方法:选取2012年9月至2015年6月该院收治的108例腹泻患儿作为观察目标,按照计算机法分为参照组和治疗组,每组54例,参照组采用常规治疗,治疗组采用金双歧联合思密达治疗,比较两组患儿的临床治疗效果、不良反应和临床症状改善时间。结果:两组均未见明显不良反应,治疗组患儿各临床症状改善时间均显著优于参照组,组间差异显著(P<0.05);治疗组总有效率92.6%与参照组总有效率75.9%进行比较,差异显著,存在统计学意义(P<0.05)。结论:金双歧联合思密达治疗小儿腹泻疗效确切,安全可靠,具有积极的临床使用和推广价值。
Objective: To evaluate and observe the efficacy of Jinshuangqi combined with Smecta in the treatment of children with diarrhea. Methods: 108 children with diarrhea treated in our hospital from September 2012 to June 2015 were selected as the observation target. According to the computer method, the patients were divided into the reference group and the treatment group, with 54 cases in each group. The treatment group received routine treatment. Jinshuangqi combined Smecta treatment, the clinical efficacy of the two groups were compared, adverse reactions and clinical symptoms improvement time. Results: There was no obvious adverse reaction in both groups. The improvement time of clinical symptom in both treatment groups was significantly better than that of the reference group (P <0.05). The total effective rate was 92.6% in the treatment group and the total effective rate 75.9% for comparison, the difference was significant, there was statistical significance (P <0.05). Conclusion: Jinshuangqi combined with Smectite treatment of children with diarrhea, accurate, safe and reliable, with a positive clinical use and promotion of value.